ARCHIVES

White House appoints NCI Director Andrew von Eschenbach acting FDA commissioner after Lester Crawford resigns.

This article is from The Cancer Letter archive.

Vol. 31 No. 35 | September 30, 2005

Download PDF Visit The Full Archive

Related Articles

Clinical Trials Approved By NCI

March 26, 2004

Upton May Leave NCI Soon, Newell Accepts Post At M.D. Anderson to Head Cancer Prevention

August 17, 1979

House Committee Aims To Cut Markup On Office-Administered Cancer Drugs.

November 16, 2001

In Brief” McKenna New ACS President, Lemaistre President Elect; Michael Potter Wins Albert Lasker Award

November 23, 1984

Breast Cancer Task Force to Issue New RFPs In July, September

July 9, 1976

NCI to Close Clinical Branch at Frederick, Move Patients, Protocols To Bethesda

May 17, 1996